Issue 10, 1994

Development of an HPLC–ICP–MS method for the determination of platinum species from new anti-tumour drugs

Abstract

The anti-tumour drug cisplatin and some of its more modern analogues has been determined by use of a HPLC–ICP–MS system. The results compare favourably with those obtained by using HPLC–ICP–AES and HPLC–electrochemical detection and are superior to those obtained by HPLC–ETAAS.

Article information

Article type
Paper

Anal. Proc., 1994,31, 295-297

Development of an HPLC–ICP–MS method for the determination of platinum species from new anti-tumour drugs

W. R. L. Cairns, L. Ebdon and S. J. Hill, Anal. Proc., 1994, 31, 295 DOI: 10.1039/AI9943100295

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements